Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Matikainen, Niina ^a   Burza, Maria Antonella ^b   Romeo, Stefano ^b   Hakkarainen, Antti ^a   Adiels, Martin ^b   Folkersen, Lasse ^c   Eriksson, Per ^c   Lundbom, Nina ^a   Ehrenborg, Ewa ^c   Orho Melander, Marju ^d   Taskinen, Marja Riitta ^a   Borén, Jan ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; SULFOTRANSFERASES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84894274848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079473     Document Type: Article

References (30)

1. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298: 299-308. doi: 10.1001/jama.298.3.299. PubMed: 17635890. (Pubitemid 47080484)
2. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298: 309-316. doi:10.1001/jama.298.3.309. PubMed: 17635891. (Pubitemid 47080485)
3. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300: 2142-2152. doi:10.1001/jama.2008.621. PubMed: 19001625.
4. Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC et al. (2010) The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 211: 1-8. doi:10.1016/j.atherosclerosis.2009.12. 027. PubMed: 20117784.
5. Zilversmit DB (1973) A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 33: 633-638. doi:10.1161/01.RES.33.6.633. PubMed: 4361710.
6. Moreton JR (1947) Atherosclerosis and Alimentary Hyperlipemia. Science 106: 190-191. doi:10.1126/science.106.2748.190. PubMed: 17749166.
7. Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW et al. (1993) Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 34: 2033-2040. PubMed: 8301224. (Pubitemid 24000952)
8. Nakajima K, Nakano T, Tokita Y, Nagamine T, Inazu A et al. (2011) Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta 412: 1306-1318. doi:10.1016/j.cca.2011.04.018. PubMed: 21531214.
9. Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O et al. (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417: 750-754. doi:10.1038/nature00804. PubMed: 12066187. (Pubitemid 34640629)
10. Williams KJ, Tabas I (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15: 551-561. doi: 10.1161/01.ATV.15.5.551. PubMed: 7749869.
11. Tabas I, Williams KJ, Borén J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116: 1832-1844. doi:10.1161/CIRCULATIONAHA.106.676890. PubMed: 17938300. (Pubitemid 350287108)
12. Proctor SD, Vine DF, Mamo JC (2002) Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol 13: 461-470. doi: 10.1097/00041433-200210000-00001. PubMed: 12352009. (Pubitemid 35231925)
13. Williams KJ, Chen K (2010) Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol 21: 218-228. doi:10.1097/MOL. 0b013e328338cabc. PubMed: 20463470.
14. Williams KJ (2008) Molecular processes that handle - and mishandle - dietary lipids. J Clin Invest 118: 3247-3259. doi:10.1172/JCI35206. PubMed: 18830418.
15. Mahley RW, Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40: 1-16. PubMed: 9869645. (Pubitemid 29022581)
16. MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A et al. (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117: 153-164. doi:10.1172/JCI29154. PubMed: 17200715. (Pubitemid 46048462)
17. Williams KJ, Fless GM, Petrie KA, Snyder ML, Brocia RW et al. (1992) Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem 267: 13284-13292. PubMed: 1320015.
18. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP et al. (1997) The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invest 100: 1611-1622. doi:10.1172/JCI119685. PubMed: 9294130. (Pubitemid 27425789)
19. Chen K, Liu ML, Schaffer L, Li M, Boden G et al. (2010) Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins. Hepatology 52: 1957-1967. doi:10.1002/hep.23916. PubMed: 21049473.
20. Hassing HC, Mooij H, Guo S, Monia BP, Chen K et al. (2012) Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia. Hepatology 55: 1746-1753. doi:10.1002/hep.25580. PubMed: 22234891.
21. Matikainen N, Mänttäri S, Westerbacka J, Vehkavaara S, Lundbom N et al. (2007) Postprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 92: 3052-3059. doi:10.1210/jc.2007-0187. PubMed: 17488790. (Pubitemid 47236370)
22. Huttunen JK, Ehnholm C, Kinnunen PKJ, Nikkilä EA (1975) An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63: 335-347. doi:10.1016/0009- 8981(75)90055-8. PubMed: 240522.
23. Lundbom J, Hakkarainen A, Fielding B, Söderlund S, Westerbacka J et al. (2010) Characterizing human adipose tissue lipids by long echo time 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatography. NMR Biomed 23: 466-472. doi:10.1002/nbm.1483. PubMed: 20099371.
24. Jackson V, Petrini J, Caidahl K, Eriksson MJ, Liska J et al. (2011) Bicuspid aortic valve leaflet morphology in relation to aortic root morphology: a study of 300 patients undergoing open-heart surgery. Eur J Cardiothorac Surg 40: e118-e124. PubMed: 21620721.
25. Folkersen L, Wågsäter D, Paloschi V, Jackson V, Petrini J et al. (2011) Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study. Molecular Medicine 17: 1365-1373. PubMed: 21968790.
26. Bjorkegren J, Packard CJ, Hamsten A, Bedford D, Caslake M et al. (1996) Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 37: 76-86. PubMed: 8820104. (Pubitemid 26052621)
27. Adiels M, Matikainen N, Westerbacka J, Söderlund S, Larsson T et al. (2012) Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity. Atherosclerosis 222: 222-228. doi:10.1016/j.atherosclerosis.2012.02.001. PubMed: 22365426.
28. Hassing C, Mooij H, Dallinga-Thie G, Dekker JM, Nijpels G et al.Genetic variation in SULF2 is associated with plasma triglyceride levels in subjects with type 2 diabetes. p. 2012. Sydney
29. Stanford KI, Bishop JR, Foley EM, Gonzales JC, Niesman IR et al. (2009) Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest 119: 3236-3245. PubMed: 19805913.
30. Stanford KI, Wang L, Castagnola J, Song D, Bishop JR et al. (2010) Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem 285: 286-294. doi:10.1074/jbc.M109.063701. PubMed: 19889634.